Filing Flows › Medtronic (MDT) › Q3 FY25
Medtronic (MDT) Q3 FY25 earnings results (third quarter fiscal 2025)
10-Q filed Feb 25, 2025
Medtronic (MDT) reported revenue of $8.3B for the third quarter fiscal 2025 (Q3 FY25), +3% from a year earlier and -1% from the quarter before. Operating margin was 19.9%, net earnings $1.3B (15.6% of revenue).
Medtronic, Q3 FY25: revenue $8.3B (+2% year over year), operating margin 19.9%, net earnings $1.3B, operating cash flow $2.6B. The chart follows the revenue to costs, profit and cash.
| Q3 FY25 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $8.3B | -1% | +3% |
| Operating profit | $1.6B | +3% | +11% |
| Net earnings | $1.3B | +2% | -2% |
| Operating cash flow | $2.6B | +168% | +4% |
| Free cash flow | $2.1B | +278% | -2% |
What changed
Revenue was $8.3B in Q3 FY25, up 3% year over year and down 1% from the previous quarter.
Operating profit was $1.6B, a 19.9% margin (up 1.5 points year over year). Of the extra revenue versus a year earlier, 80% reached operating profit, above the 18% margin then. Total costs grew 1% against revenue growth of 3%. Net earnings were $1.3B, down 2% year over year. The effective tax rate was 15.4%.
Operating cash flow was $2.6B (up 4% year over year), 197% of net earnings. Non-cash charges added back $0.68B of depreciation and amortization and $0.10B of share-based compensation. Working capital and other items added $0.49B. Capital expenditures of $0.48B left free cash flow of $2.1B.
Questions
What was Medtronic's revenue in the third quarter fiscal 2025?
Medtronic (MDT) reported revenue of $8.3B for the third quarter fiscal 2025 (Q3 FY25), +3% from a year earlier and -1% from the quarter before.
Was Medtronic profitable in the third quarter fiscal 2025?
Operating profit was $1.6B (19.9% of revenue) and net earnings $1.3B.
Source: Medtronic 10-Q on SEC EDGAR.